吲哚衍生物作为STING降解剂的发现

IF 6 2区 医学 Q1 CHEMISTRY, MEDICINAL
Yuxiang An , Yan Zhang , Xin Luo , Yaohan Lan , Meiyu Geng , Wenhu Duan , Zuoquan Xie , Hefeng Zhang
{"title":"吲哚衍生物作为STING降解剂的发现","authors":"Yuxiang An ,&nbsp;Yan Zhang ,&nbsp;Xin Luo ,&nbsp;Yaohan Lan ,&nbsp;Meiyu Geng ,&nbsp;Wenhu Duan ,&nbsp;Zuoquan Xie ,&nbsp;Hefeng Zhang","doi":"10.1016/j.ejmech.2025.117747","DOIUrl":null,"url":null,"abstract":"<div><div>Aberrant activation of the stimulator of interferon genes (STING) pathway is associated with the development of various inflammatory and autoimmune diseases. Targeting STING for degradation represents a novel strategy for the treatment of these diseases. In this study, we designed and synthesized a series of STING-PROTACs based on a nitro-free covalent warhead and different E3 ligase binders. The representative compound <strong>2h</strong> specifically degraded STING protein through the proteasome pathway with a DC<sub>50</sub> value of 3.23 μM and exhibited sustained degradation activity over 72 h. Further biological studies demonstrated that compound <strong>2h</strong> inhibited STING signaling and effectively suppressed immune-inflammatory cytokines both <em>in vitro</em> and <em>in vivo</em>. Moreover, compound <strong>2h</strong> offered better safety compared to its warhead molecule and SP23. Collectively, compound <strong>2h</strong> is a potent nitro-free covalent STING degrader and warrants further investigation.</div></div>","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"294 ","pages":"Article 117747"},"PeriodicalIF":6.0000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Discovery of indole derivatives as STING degraders\",\"authors\":\"Yuxiang An ,&nbsp;Yan Zhang ,&nbsp;Xin Luo ,&nbsp;Yaohan Lan ,&nbsp;Meiyu Geng ,&nbsp;Wenhu Duan ,&nbsp;Zuoquan Xie ,&nbsp;Hefeng Zhang\",\"doi\":\"10.1016/j.ejmech.2025.117747\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Aberrant activation of the stimulator of interferon genes (STING) pathway is associated with the development of various inflammatory and autoimmune diseases. Targeting STING for degradation represents a novel strategy for the treatment of these diseases. In this study, we designed and synthesized a series of STING-PROTACs based on a nitro-free covalent warhead and different E3 ligase binders. The representative compound <strong>2h</strong> specifically degraded STING protein through the proteasome pathway with a DC<sub>50</sub> value of 3.23 μM and exhibited sustained degradation activity over 72 h. Further biological studies demonstrated that compound <strong>2h</strong> inhibited STING signaling and effectively suppressed immune-inflammatory cytokines both <em>in vitro</em> and <em>in vivo</em>. Moreover, compound <strong>2h</strong> offered better safety compared to its warhead molecule and SP23. Collectively, compound <strong>2h</strong> is a potent nitro-free covalent STING degrader and warrants further investigation.</div></div>\",\"PeriodicalId\":314,\"journal\":{\"name\":\"European Journal of Medicinal Chemistry\",\"volume\":\"294 \",\"pages\":\"Article 117747\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-05-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0223523425005124\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425005124","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

干扰素刺激因子(STING)通路的异常激活与各种炎症和自身免疫性疾病的发生有关。靶向STING降解是治疗这些疾病的一种新策略。在本研究中,我们设计并合成了一系列基于无硝基共价战斗部和不同E3连接酶结合剂的STING-PROTACs。代表性化合物2h通过蛋白酶体途径特异性降解STING蛋白,其DC50值为3.23 μM,并具有72 h的持续降解活性。进一步的生物学研究表明,化合物2h在体外和体内均能抑制STING信号传导,有效抑制免疫炎症因子。化合物2h相对于其战斗部分子和SP23具有更好的安全性。总的来说,化合物2h是一种有效的无氮共价STING降解剂,值得进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Discovery of indole derivatives as STING degraders

Discovery of indole derivatives as STING degraders
Aberrant activation of the stimulator of interferon genes (STING) pathway is associated with the development of various inflammatory and autoimmune diseases. Targeting STING for degradation represents a novel strategy for the treatment of these diseases. In this study, we designed and synthesized a series of STING-PROTACs based on a nitro-free covalent warhead and different E3 ligase binders. The representative compound 2h specifically degraded STING protein through the proteasome pathway with a DC50 value of 3.23 μM and exhibited sustained degradation activity over 72 h. Further biological studies demonstrated that compound 2h inhibited STING signaling and effectively suppressed immune-inflammatory cytokines both in vitro and in vivo. Moreover, compound 2h offered better safety compared to its warhead molecule and SP23. Collectively, compound 2h is a potent nitro-free covalent STING degrader and warrants further investigation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍: The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信